NCT06132776View on ClinicalTrials.gov

The Mamma HiToP Study

NARecruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

November 3, 2023

Primary Completion Date

November 2, 2024

Study Completion Date

December 31, 2024

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

HiToP 191 PNP

High tone therapy

DEVICE

Placebo device

Placebo therapy

Trial Locations (1)

Unknown

RECRUITING

Clinics Donaustadt, Ottakring, Hietzing, Vienna

All Listed Sponsors

lead

Vienna Hospital Association

OTHER_GOV